Tower Research Capital LLC (Trc) Oric Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 14,661 shares of ORIC stock, worth $117,288. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,661

Previous 1,277 1048.08%

Holding current value

$117,288

Previous $13,000 807.69%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$7.68 - $10.3 $102,789 - $137,855	13,384 Added 1048.08%	14,661 $118,000
Q3 2024 Nov 14, 2024	SELL	$7.52 - $11.9 $28,019 - $44,339	-3,726 Reduced 74.48%	1,277 $13,000
Q2 2024 Aug 13, 2024	BUY	$6.63 - $12.93 $28,197 - $54,991	4,253 Added 567.07%	5,003 $35,000
Q1 2024 May 15, 2024	SELL	$8.04 - $16.03 $68,380 - $136,335	-8,505 Reduced 91.9%	750 $10,000
Q4 2023 Feb 13, 2024	BUY	$5.41 - $9.43 $8,206 - $14,305	1,517 Added 19.6%	9,255 $85,000
Q3 2023 Nov 14, 2023	BUY	$6.05 - $9.28 $34,091 - $52,292	5,635 Added 267.95%	7,738 $46,000
Q2 2023 Aug 14, 2023	BUY	$4.95 - $8.4 $10,409 - $17,665	2,103 New	2,103 $16,000
Q4 2022 Feb 10, 2023	BUY	$2.41 - $5.89 $5,085 - $12,427	2,110 Added 30.29%	9,077 $53,000
Q3 2022 Nov 10, 2022	SELL	$3.15 - $5.24 $16,146 - $26,860	-5,126 Reduced 42.39%	6,967 $22,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.07 $14,679 - $38,439	-5,437 Reduced 31.02%	12,093 $55,000
Q1 2022 May 12, 2022	BUY	$4.54 - $16.1 $75,895 - $269,143	16,717 Added 2056.21%	17,530 $94,000
Q4 2021 Feb 14, 2022	SELL	$12.01 - $20.3 $20,380 - $34,449	-1,697 Reduced 67.61%	813 $12,000
Q3 2021 Nov 15, 2021	BUY	$15.9 - $25.22 $10,287 - $16,317	647 Added 34.73%	2,510 $53,000
Q2 2021 Aug 16, 2021	BUY	$17.37 - $25.34 $5,402 - $7,880	311 Added 20.04%	1,863 $32,000
Q1 2021 May 17, 2021	SELL	$23.67 - $36.85 $25,634 - $39,908	-1,083 Reduced 41.1%	1,552 $38,000
Q4 2020 Feb 16, 2021	SELL	$20.32 - $39.8 $103,489 - $202,701	-5,093 Reduced 65.9%	2,635 $89,000
Q3 2020 Nov 16, 2020	BUY	$19.5 - $31.26 $142,155 - $227,885	7,290 Added 1664.38%	7,728 $193,000
Q2 2020 Aug 13, 2020	BUY	$25.68 - $38.12 $11,247 - $16,696	438 New	438 $15,000

Others Institutions Holding ORIC

# of Institutions

132

Shares Held

67.3M

Call Options Held

404K

Put Options Held

6.4K

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $317M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Oric Pharmaceuticals, Inc. Transaction History